Literature DB >> 8581272

Changes in benzodiazepine-GABA receptor coupling in an accumbens-habenula circuit after chronic diazepam treatment.

R R Brett1, J A Pratt.   

Abstract

1. The effects of subacute and of chronic diazepam treatment upon binding to the GABAA receptor have been examined by use of receptor autoradiography for determining flunitrazepam (FNZP) binding, GABA enhancement of FNZP binding. SR 95531 2-(3'-carboxy-2',propyl)-3-amino-6-p-methoxyphenylpyridazinium bromide) binding and GABA binding in parallel sections from rat brain. Prior to the autoradiographic procedures, a behavioural assessment of the rats was made in the elevated plus-maze test of anxiety. 2. Rats receiving diazepam either subacutely (3 days) or chronically (28 days) by both continuous release, from previously implanted subcutaneous silastic capsules, or by daily injection (5 mg kg-1) did not display changes in FNZP or GABA binding in any of the 47 brain structures analysed. Similarly, there were no significant effects of treatment upon mean total entries or on the open:total ratio for entries in the elevated plus-maze. 3. There were reductions in the GABA enhancement of FNZP binding in the nucleus accumbens and central grey after subacute diazepam treatment. This effect persisted in the nucleus accumbens after chronic treatment. Less marked effects occurred in the lateral habenula, dorsal raphe and substantia nigra pars compacta. In the dorsal tegmental nucleus, GABA enhancement of FNZP binding was enhanced after chronic treatment and this was accompanied by reductions in SR 95531 binding. Treatment did not otherwise affect SR 95531 binding, with the exception of the dorsal raphe where binding was decreased after subacute treatment. 4. In general, the patterns of binding produced by the two different treatment routes were very similar. However, SR 95531 binding was lower in certain hippocampal fields in the i.p. treated animals compared to the rats implanted with silastic capsules. 5. It is concluded that repeated administration of diazepam evokes changes in benzodiazepine and GABA receptor coupling, and to a lesser extent changes in low affinity GABA binding, in certain interrelated brain structures of which an accumbens-habenula circuit is a central feature. These changes occur soon after the initiation of diazepam treatment, suggesting that they are unlikely to account for tolerance to the anxiolytic effects of diazepam but may trigger and/or accompany other critical neurochemical events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581272      PMCID: PMC1909033          DOI: 10.1111/j.1476-5381.1995.tb15083.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  51 in total

1.  GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.

Authors:  R W Olsen; R T McCabe; J K Wamsley
Journal:  J Chem Neuroanat       Date:  1990 Jan-Feb       Impact factor: 3.052

2.  Local cerebral glucose utilization following subacute and chronic diazepam pretreatment: differential tolerance.

Authors:  D J Laurie; J A Pratt
Journal:  Brain Res       Date:  1989-12-11       Impact factor: 3.252

3.  Binding of [3H]-muscimol to GABAA sites in the guinea-pig urinary bladder: biochemical assay and autoradiography.

Authors:  S L Erdö; M C Mione; F Amenta; J R Wolff
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

4.  Continuous release of diazepam: electrophysiological, biochemical and behavioral consequences.

Authors:  D W Gallager; A B Malcolm; S A Anderson; S F Gonsalves
Journal:  Brain Res       Date:  1985-09-02       Impact factor: 3.252

5.  Regional GABA/benzodiazepine receptor/chloride channel coupling after acute and chronic benzodiazepine treatment.

Authors:  E I Tietz; T H Chiu; H C Rosenberg
Journal:  Eur J Pharmacol       Date:  1989-08-11       Impact factor: 4.432

6.  A novel GABAA antagonist [3H]SR 95531: microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligands.

Authors:  R T McCabe; J K Wamsley; J P Yezuita; R W Olsen
Journal:  Synapse       Date:  1988       Impact factor: 2.562

7.  Altered gamma-aminobutyric acid/benzodiazepine interaction after chronic diazepam exposure.

Authors:  C Heninger; D W Gallager
Journal:  Neuropharmacology       Date:  1988-10       Impact factor: 5.250

8.  Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function.

Authors:  L G Miller; D J Greenblatt; R B Roy; W R Summer; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

9.  Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased gamma-aminobutyric acidA receptor function.

Authors:  L G Miller; D J Greenblatt; J G Barnhill; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

10.  Osmotic shock: a method to eliminate endogenous gamma-aminobutyric acid and account for the influence on benzodiazepine binding affinity in autoradiographic studies.

Authors:  R T McCabe; R W Olsen; J P Yezuita; J K Wamsley
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

View more
  5 in total

1.  Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?

Authors:  Christiaan H Vinkers; Berend Olivier
Journal:  Adv Pharmacol Sci       Date:  2012-03-29

2.  NMDA Receptors and NO:cGMP Signaling Pathway Mediate the Diazepam-Induced Sensitization to Withdrawal Signs in Mice.

Authors:  Sylwia Talarek; Joanna Listos; Jolanta Orzelska-Gorka; Anna Serefko; Jolanta Kotlińska
Journal:  Neurotox Res       Date:  2017-09-21       Impact factor: 3.911

3.  Psychopharmacological effects and safety of styryl-2-pyrones and dihydrostyryl-2-pyrones-rich fraction from Polygala sabulosa: absence of withdrawal syndrome and tolerance to anxiolytic-like and anticonvulsant effects.

Authors:  Filipe Silveira Duarte; Marcelo Duzzioni; Rafael Luiz Prim; Alcíbia Maia Cardozo; Claudia Regina Dos Santos; Maria Goretti da Silva; Maria Beatriz Cacese Shiozawa; Beatriz Garcia Mendes; Tiago Tizziani; Inês Maria Costa Brighente; Moacir Geraldo Pizzolatti; Thereza Christina Monteiro de Lima
Journal:  J Pharm Pharmacol       Date:  2018-06-28       Impact factor: 3.765

4.  Neonatal Clonazepam Administration Induced Long-Lasting Changes in GABAA and GABAB Receptors.

Authors:  Hana Kubová; Zdeňka Bendová; Simona Moravcová; Dominika Pačesová; Luisa Rocha; Pavel Mareš
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

5.  Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding.

Authors:  Luisa Rocha
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.